Ebola | |||||
NEWS | |||||
Lumos Pharma Announces Sale of Priority Review Voucher ... Merck, for the prevention of the Zaire Ebola virus disease. Under the terms of the original license agreement Lumos Pharma is entitled to retain 60% ...
| |||||
AHF: Regional Unity Needed to Stop COVID-19 in Latin America ... infectious disease outbreaks, such as Ebola, Zika, and now COVID-19 – AHF is deeply concerned over the lack of coordination between countries, ...
| |||||
New heart problems seen in recovered COVID-19 patients The FDA has allowed for antiviral drug remdesivir, previously tested on humans with Ebola, to treat more severe cases of COVID-19 in adults and ...
| |||||
Iran produces anti-corona medicine "Tocilizumab" Remdesivir was studied in clinical trials for Ebola virus infections but showed limited benefit. Remdesivir has been shown to inhibit replication of other ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar